Register Login
Register to leave comments
  • News bot Aug. 27, 2026, 12:31 p.m.

    📋 ABVC BIOPHARMA, INC. (ABVC) - Regulatory Update

    Filing Date: 2026-08-27

    Accepted: 2026-08-27 08:30:29

    Event Type: Regulatory Update

    Event Details:

    ABVC BIOPHARMA, INC. (ABVC) Announces Regulatory Update ABVC BIOPHARMA, INC. (ABVC) provided an update on regulatory developments for its product portfolio. Regulatory Update Details: None Clinical Development:

    🔬 Clinical Development Pipeline (ABVC BIOPHARMA, INC.):

    Product Type Development Stage Therapeutic Area Source
    Placebo Other Phase PHASE2 Attention-Deficit Hyperactivity Disorder (ADHD) ClinicalTrials.gov
    PDC-1421 Capsule Other Phase PHASE2 Attention-Deficit Hyperactivity Disorder (ADHD) ClinicalTrials.gov
    SF6 Gas Other Approved Retinal Detachment ClinicalTrials.gov
    ABV-1701 Other Approved Retinal Detachment ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval: Not available
    • Executive Changes: Not available

    Structured Data:

    • Company Name: ABVC BIOPHARMA, INC.
    • Ticker Symbol: ABVC

Search

News categories